Attention Deficit Disorder With Hyperactivity (ADHD) Clinical Trials
2 recruiting trials for Attention Deficit Disorder With Hyperactivity (ADHD). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Attention Deficit Disorder With Hyperactivity (ADHD) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fundació Sant Joan de Déu (1), Kai Hwang (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Behavioral Parent Training (BPT) (behavioral, 1 trial), followed by Behavioral Parent Training (BPT) + Support of AI app, High-resolution fMRI during working memory, cognitive control, and decision-making tasks.
Track Attention Deficit Disorder With Hyperactivity (ADHD) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors
The goal of this clinical trial is to learn if adding an artificial intelligence (AI) application called to standard Behavioral Parent Training (BPT) helps families with children...
Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility
The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Attention Deficit Disorder With Hyperactivity (ADHD), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Attention Deficit Disorder With Hyperactivity (ADHD), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Attention Deficit Disorder With Hyperactivity (ADHD), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.